Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.
    Difference
    2%
    Check dated 2025-06-05T07:41:20.000Z thumbnail image
  3. Check
    24 days ago
    No Change Detected
  4. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:24:17.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page has undergone significant content changes regarding a clinical study on Parkinson's Disease, with the removal of detailed study descriptions and key inclusion/exclusion criteria, while retaining some core identifiers like the study name and revision number.
    Difference
    34%
    Check dated 2025-04-16T11:14:28.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:40:31.000Z thumbnail image
  7. Check
    110 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T20:18:12.000Z thumbnail image
  8. Check
    125 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:29:40.000Z thumbnail image

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.